目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 44)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 50)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET: MARKET SIZE ESTIMATION FOR SUPPLY-SIDE ANALYSIS (2022)
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS FOR 2022
2.2.1 PRIMARY INSIGHTS
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
FIGURE 7 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 8 MARKET: CAGR PROJECTIONS FOR FORECAST PERIOD
FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 DATA TRIANGULATION APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023-2028 (USD MILLION)

3 EXECUTIVE SUMMARY (Page No. - 63)
FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 15 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 16 MARKET: GEOGRAPHIC SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 68)
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
FIGURE 17 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: MARKET, BY PRODUCT AND COUNTRY
FIGURE 18 KITS DOMINATED NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2023
4.3 MARKET SHARE, BY TYPE, 2022
FIGURE 19 PLASMID DNA ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 MARKET SHARE, BY PRODUCT, 2022
FIGURE 20 KITS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 MARKET SHARE, BY METHOD, 2022
FIGURE 21 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2022
4.6 MARKET SHARE, BY APPLICATION, 2022
FIGURE 22 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.7 MARKET SHARE, BY END USER, 2022
FIGURE 23 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.8 GEOGRAPHICAL SNAPSHOT OF MARKET
FIGURE 24 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 73)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing R&D activities
5.2.1.2 Technological advancements and increasing automation
5.2.1.3 Growing demand for molecular diagnostics
TABLE 5 ESTIMATED NUMBER OF NEW CANCER CASES GLOBALLY, BY TYPE OF CANCER, 2020 VS. 2025
TABLE 6 GLOBAL CANCER INCIDENCE, BY REGION, 2020 VS. 2025
5.2.2 RESTRAINTS
5.2.2.1 High cost of automated instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.3.2 Improving regulatory and reimbursement scenario
5.2.3.3 Molecular diagnostics and personalized medicine
5.2.4 CHALLENGES
5.2.4.1 Operational barriers and shortage of skilled professionals
5.2.4.2 Introduction of alternative technologies
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 26 REVENUE SHIFT & NEW REVENUE POCKETS FOR MARKET PROVIDERS
5.4 PATENT ANALYSIS
FIGURE 27 MARKET: PATENT APPLICATIONS, OCTOBER 2013-OCTOBER 2023
TABLE 7 MARKET: INDICATIVE LIST OF PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 28 MARKET: VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 29 MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
TABLE 8 MARKET: ECOSYSTEM ANALYSIS
5.8 KEY CONFERENCES & EVENTS IN 2023-2024
TABLE 9 MARKET: DETAILED LIST OF CONFERENCES & EVENTS IN 2023-2024
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE, BY PRODUCT
TABLE 10 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, 2022-2023 (USD)
5.9.2 AVERAGE SELLING PRICE, BY REGION
TABLE 11 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, BY REGION, 2022-2023 (USD)
5.10 TECHNOLOGY ANALYSIS
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 12 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF SUPPLIERS
5.11.4 BARGAINING POWER OF BUYERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 REGULATORY ANALYSIS
5.12.1 REGULATORY BODIES
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS
5.13.2 BUYING CRITERIA FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (Page No. - 98)
6.1 INTRODUCTION
TABLE 18 MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
6.2 KITS
6.2.1 KITS TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD
TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 20 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 21 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 23 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3 REAGENTS
6.3.1 AVAILABILITY OF READY-TO-USE REAGENTS TO DRIVE GROWTH
TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 26 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 27 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 29 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.4 INSTRUMENTS
TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 34 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 36 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.4.1 AUTOMATIC INSTRUMENTS
6.4.1.1 Benefits of automatic instruments to drive growth
TABLE 38 MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 39 NORTH AMERICA: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 40 EUROPE: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 42 LATIN AMERICA: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
6.4.2 MANUAL INSTRUMENTS
6.4.2.1 Growing demand for nucleic acid isolation and purification in research and clinical applications to drive growth
TABLE 44 MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 45 NORTH AMERICA: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 46 EUROPE: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 47 ASIA PACIFIC: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 48 LATIN AMERICA: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA: MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD (Page No. - 117)
7.1 INTRODUCTION
TABLE 50 MARKET, BY METHOD, 2021-2028 (USD MILLION)
7.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
7.2.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
TABLE 51 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 52 NORTH AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 53 EUROPE: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 55 LATIN AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3 REAGENT-BASED ISOLATION AND PURIFICATION
7.3.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
TABLE 57 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 58 NORTH AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 59 EUROPE: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 60 ASIA PACIFIC: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 61 LATIN AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.4 COLUMN-BASED ISOLATION AND PURIFICATION
7.4.1 GROWING POPULARITY OF COLUMN-BASED ISOLATION AND PURIFICATION IN CURRENT KITS TO BOOST MARKET
TABLE 63 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 64 NORTH AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 65 EUROPE: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 67 LATIN AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.5 OTHER ISOLATION AND PURIFICATION METHODS
TABLE 69 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 70 NORTH AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 71 EUROPE: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 72 ASIA PACIFIC: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 73 LATIN AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE (Page No. - 131)
8.1 INTRODUCTION
TABLE 75 MARKET, BY TYPE, 2021-2028 (USD MILLION)
8.2 PLASMID DNA ISOLATION AND PURIFICATION
8.2.1 PLASMID DNA ISOLATION AND PURIFICATION TO ACCOUNT FOR LARGEST SHARE OF MARKET
TABLE 76 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 77 NORTH AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 78 EUROPE: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 80 LATIN AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 81 MIDDLE EAST & AFRICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
8.3 TOTAL RNA ISOLATION AND PURIFICATION
8.3.1 WIDE USE OF TOTAL RNA ISOLATION AND PURIFICATION FOR RESEARCH AND DIAGNOSTIC APPLICATIONS TO BOOST MARKET
TABLE 82 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 83 NORTH AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 84 EUROPE: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 85 ASIA PACIFIC: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 86 LATIN AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 87 MIDDLE EAST & AFRICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
8.4 GENOMIC DNA ISOLATION AND PURIFICATION
8.4.1 IMPORTANCE OF GENOMIC DNA ISOLATION IN GENETIC-BASED TESTS TO SUPPORT GROWTH
TABLE 88 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 89 NORTH AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 90 EUROPE: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 92 LATIN AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 93 MIDDLE EAST & AFRICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
8.5 MESSENGER RNA ISOLATION AND PURIFICATION
8.5.1 ROLE PLAYED BY MESSENGER RNA ISOLATION AND PURIFICATION IN GENE EXPRESSION AND TRANSCRIPTOMICS TO DRIVE GROWTH
TABLE 94 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 95 NORTH AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 96 EUROPE: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 98 LATIN AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 99 MIDDLE EAST & AFRICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
8.6.1 ABILITY OF CIRCULATING NAIP TO ENABLE COLLECTION OF GENETIC INFORMATION FROM BODY FLUIDS TO BOOST ADOPTION
TABLE 100 MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 101 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 102 EUROPE: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 103 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 104 LATIN AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: MARKET, BY REGION, 2021-2028 (USD MILLION)
8.7 MICRORNA ISOLATION AND PURIFICATION
8.7.1 GROWING APPLICATIONS OF MICRORNA ISOLATION AND PURIFICATION IN DRUG DEVELOPMENT RESEARCH TO FUEL GROWTH
TABLE 106 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 107 NORTH AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 108 EUROPE: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 110 LATIN AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
8.8 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES
TABLE 112 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 113 NORTH AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 114 EUROPE: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 115 ASIA PACIFIC: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 116 LATIN AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021-2028 (USD MILLION)

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION (Page No. - 154)
9.1 INTRODUCTION
TABLE 118 MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
9.2 DIAGNOSTICS
9.2.1 DIAGNOSTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 119 MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 120 NORTH AMERICA: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 121 EUROPE: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 123 LATIN AMERICA: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
9.3 DRUG DISCOVERY & DEVELOPMENT
9.3.1 POTENTIAL OF NAIP TO HELP IN DEVELOPMENT OF DRUGS FOR RARE DISEASES TO BOOST MARKET
TABLE 125 MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 126 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 127 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 129 LATIN AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 130 MIDDLE EAST & AFRICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
9.4 PERSONALIZED MEDICINE
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE GROWTH
TABLE 131 MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 132 NORTH AMERICA: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 133 EUROPE: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 135 LATIN AMERICA: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
9.5 AGRICULTURE & ANIMAL RESEARCH
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
TABLE 137 MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 138 NORTH AMERICA: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 139 EUROPE: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 140 ASIA PACIFIC: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 141 LATIN AMERICA: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
9.6 OTHER APPLICATIONS
TABLE 143 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 144 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 145 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 146 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 147 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER (Page No. - 173)
10.1 INTRODUCTION
TABLE 149 MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2 HOSPITALS & DIAGNOSTIC CENTERS
10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
TABLE 150 MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 151 NORTH AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 152 EUROPE: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 153 ASIA PACIFIC: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 154 LATIN AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
TABLE 156 MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
TABLE 157 NORTH AMERICA: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 158 EUROPE: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 159 ASIA PACIFIC: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 160 LATIN AMERICA: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 161 MIDDLE EAST & AFRICA: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH
TABLE 162 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 163 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 164 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 166 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
10.5 CONTRACT RESEARCH ORGANIZATIONS
10.5.1 CONTRACT RESEARCH ORGANIZATIONS TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
TABLE 168 MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 169 NORTH AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 170 EUROPE: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 172 LATIN AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 173 MIDDLE EAST & AFRICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
10.6 OTHER END USERS
TABLE 174 MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 175 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 176 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 177 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 178 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION (Page No. - 193)
11.1 INTRODUCTION
TABLE 180 MARKET, BY REGION, 2021-2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 32 NORTH AMERICA: MARKET SNAPSHOT
TABLE 181 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 182 NORTH AMERICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 183 NORTH AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 184 NORTH AMERICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 185 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 186 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 187 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.1 US
11.2.1.1 Government and private funding to support market growth
TABLE 188 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 189 US: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 190 US: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 191 US: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 192 US: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 193 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growing investments in genomics to boost market demand
TABLE 194 CANADA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 195 CANADA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 196 CANADA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 197 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 198 CANADA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 199 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.2.3 NORTH AMERICA: RECESSION IMPACT
11.3 EUROPE
TABLE 200 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 201 EUROPE: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 202 EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 203 EUROPE: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 204 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 205 EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 206 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany to dominate market in Europe
TABLE 207 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027
TABLE 208 GERMANY: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 209 GERMANY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 210 GERMANY: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 211 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 212 GERMANY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 213 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.2 UK
11.3.2.1 Government support for research through investments, funds, and grants to support market growth
TABLE 214 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 215 UK: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 216 UK: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 217 UK: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 218 UK: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 219 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High cancer burden to drive market growth
TABLE 220 FRANCE: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 221 FRANCE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 222 FRANCE: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 223 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 224 FRANCE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 225 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Government support to drive market growth in Italy
TABLE 226 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 227 ITALY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 228 ITALY: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 229 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 230 ITALY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 231 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 High adoption of advanced diagnostic technologies to drive market growth in Spain
TABLE 232 SPAIN: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 233 SPAIN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 234 SPAIN: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 235 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 236 SPAIN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 237 SPAIN: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 238 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 239 REST OF EUROPE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 240 REST OF EUROPE: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 241 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 242 REST OF EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 243 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.3.7 EUROPE: RECESSION IMPACT
11.4 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 244 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 245 ASIA PACIFIC: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 246 ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 247 ASIA PACIFIC: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 248 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 249 ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 250 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.1 CHINA
11.4.1.1 China to register highest growth in nucleic acid isolation and purification market in Asia Pacific region
TABLE 251 CHINA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 252 CHINA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 253 CHINA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 254 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 255 CHINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 256 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Growing number of conferences & workshops to drive market growth
TABLE 257 JAPAN: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 258 JAPAN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 259 JAPAN: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 260 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 261 JAPAN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 262 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Focused initiatives in pharmaceutical & biotechnology industries to drive market growth
TABLE 263 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 264 INDIA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 265 INDIA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 266 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 267 INDIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 268 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.4 SOUTH KOREA
11.4.4.1 Support from governments to drive market in region
TABLE 269 SOUTH KOREA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 270 SOUTH KOREA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 271 SOUTH KOREA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 272 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 273 SOUTH KOREA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 274 SOUTH KOREA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC (ROAPAC)
TABLE 275 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 276 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 277 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 278 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 279 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 280 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.4.6 ASIA PACIFIC: RECESSION IMPACT
11.5 LATIN AMERICA
TABLE 281 LATIN AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 282 LATIN AMERICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 283 LATIN AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 284 LATIN AMERICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 285 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 286 LATIN AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 287 LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Brazil to dominate LATAM market
TABLE 288 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 289 BRAZIL: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 290 BRAZIL: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 291 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 292 BRAZIL: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 293 BRAZIL: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 Favorable trade agreements to support imports and improve access to NAIP instruments in Mexico
TABLE 294 MEXICO: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 295 MEXICO: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 296 MEXICO: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 297 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 298 MEXICO: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 299 MEXICO: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
TABLE 300 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 301 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 302 REST OF LATIN AMERICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 303 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 304 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 305 REST OF LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.5.4 LATIN AMERICA: RECESSION IMPACT
11.6 MIDDLE EAST & AFRICA
TABLE 306 MIDDLE EAST & AFRICA: MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 307 MIDDLE EAST & AFRICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 308 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 309 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 310 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 311 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 312 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.6.1 MIDDLE EAST
11.6.1.1 Growing focus on molecular diagnostics and research to drive market
TABLE 313 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 314 MIDDLE EAST: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 315 MIDDLE EAST: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 316 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 317 MIDDLE EAST: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 318 MIDDLE EAST: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.6.2 AFRICA
11.6.2.1 Government support for research studies to fuel growth
TABLE 319 AFRICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 320 AFRICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 321 AFRICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 322 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 323 AFRICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 324 AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
11.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE (Page No. - 275)
12.1 INTRODUCTION
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
TABLE 325 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: STRATEGIES ADOPTED
12.3 REVENUE ANALYSIS
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2018-2022)
12.4 MARKET SHARE ANALYSIS
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
TABLE 326 MARKET: DEGREE OF COMPETITION
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 36 COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT ANALYSIS
12.5.5.1 Company footprint
TABLE 327 COMPANY FOOTPRINT ANALYSIS: KEY PLAYERS
12.5.5.2 Company product footprint
TABLE 328 MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
12.5.5.3 Company regional footprint
TABLE 329 MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
12.6 START-UP/SME EVALUATION MATRIX
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 37 START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING
TABLE 330 MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 331 MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
12.7 COMPETITIVE SCENARIO AND TRENDS
12.7.1 PRODUCT LAUNCHES
TABLE 332 MARKET: PRODUCT LAUNCHES, JANUARY 2020-OCTOBER 2023
12.7.2 DEALS
TABLE 333 MARKET: DEALS, JANUARY 2020 TO OCTOBER 2023
12.7.3 OTHER DEVELOPMENTS
TABLE 334 MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO OCTOBER 2023

13 COMPANY PROFILES (Page No. - 294)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
13.1 MAJOR PLAYERS
13.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 335 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
13.1.2 QIAGEN
TABLE 336 QIAGEN: BUSINESS OVERVIEW
FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
13.1.3 F. HOFFMANN-LA ROCHE LTD.
TABLE 337 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
13.1.4 MERCK KGAA
TABLE 338 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
13.1.5 PROMEGA CORPORATION
TABLE 339 PROMEGA CORPORATION: BUSINESS OVERVIEW
13.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 340 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
13.1.7 DANAHER
TABLE 341 DANAHER: BUSINESS OVERVIEW
FIGURE 43 DANAHER: COMPANY SNAPSHOT (2022)
13.1.8 BIO-RAD LABORATORIES, INC.
TABLE 342 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
13.1.9 ILLUMINA, INC.
TABLE 343 ILLUMINA, INC.: BUSINESS OVERVIEW
FIGURE 45 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
13.1.10 TAKARA BIO INC.
TABLE 344 TAKARA BIO INC.: BUSINESS OVERVIEW
FIGURE 46 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
13.1.11 NEW ENGLAND BIOLABS
TABLE 345 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
13.1.12 ABCAM PLC
TABLE 346 ABCAM PLC: BUSINESS OVERVIEW
FIGURE 47 ABCAM PLC: COMPANY SNAPSHOT (2022)
13.2 OTHER COMPANIES
13.2.1 KILPEST INDIA LIMITED
TABLE 347 KILPEST INDIA LIMITED: COMPANY OVERVIEW
13.2.2 APICAL SCIENTIFIC SDN. BHD.
TABLE 348 APICAL SCIENTIFIC SDN. BHD.: COMPANY OVERVIEW
13.2.3 ENDRESS+HAUSER GROUP SERVICES AG
TABLE 349 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW
13.2.4 GENAXXON BIOSCIENCE GMBH
TABLE 350 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW
13.2.5 LGC BIOSEARCH TECHNOLOGIES
TABLE 351 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW
13.2.6 ZYMO RESEARCH CORPORATION
TABLE 352 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
13.2.7 NORGEN BIOTEK CORP.
TABLE 353 NORGEN BIOTEK CORP.: COMPANY OVERVIEW
13.2.8 OMEGA BIO-TEK, INC.
TABLE 354 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW
13.2.9 FAVORGEN BIOTECH CORPORATION
TABLE 355 FAVORGEN BIOTECH CORPORATION: COMPANY OVERVIEW
13.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD.
TABLE 356 TIANGEN BIOTECH(BEIJING)CO., LTD.: COMPANY OVERVIEW
13.2.11 AUTOGEN INC.
TABLE 357 AUTOGEN INC.: COMPANY OVERVIEW
13.2.12 PCR BIOSYSTEMS
TABLE 358 PCR BIOSYSTEMS: COMPANY OVERVIEW
13.2.13 BIOGENUIX
TABLE 359 BIOGENUIX: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 381)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS